BioCryst Pharmaceuticals Inc (BCRX) Stock Price, Quote, News & History

BCRXNASDAQ
$8.29
-0.08-0.96%
At close: May 22, 5:00 PM EST
$8.44
0.151.81%
After Hours: May 22, 5:58 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
313.10M
Investing Cash Flow (TTM)
-309.44M
Financing Cash Flow (TTM)
62.09M
Free Cash Flow (TTM)
310.37M
Capital Expenditure (TTM)
-2.73M
Net Change in Cash (TTM)
65.75M

Analyst Trends and Forecast

1
Dec 25
1
Jan
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.69B
PE Ratio (TTM)
-
PE Ratio (FWD)
72.99
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.13
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-21.16%
Earnings Yield % (FWD)
1.37%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
6.07
Book Value / Share
-$2.18

Company Debt

Total Debt
$802.38M
LT Debt
$802.38M
LT Debt Issuance (TTM)
$400.00M
LT Debt Repayment (TTM)
-$301.82M
Total Cash
$171.59M
Debt to Equity
-
Issuance of Debt (TTM)
$98.18M
Repayment of Debt (TTM)
-$301.82M

Key Statistics

Open
$8.35
Close
$8.29
Volume / Avg.
4.17M / 5.47M
Day Range
$8.22 - $8.54
52 Wk Range
6.00 - 11.31
Market Cap
$2.15B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
14.83%
Days to Cover
11.11

About

Sector
Health Care
Industry
Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioCryst Pharma (BCRX) stock?

A

You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BioCryst Pharma (BCRX) competitors?

A

There are no as such competitors for BioCryst Pharma.

Q

What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?

A

BioCryst Pharma has a consensus price target of $20.07.

Q

What is the current price for BioCryst Pharma (BCRX)?

A

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $8.44 last updated May 22, 2026 at 5:58 PM EDT.

Q

Does BioCryst Pharma (BCRX) pay a dividend?

A

There are no upcoming dividends for BioCryst Pharma.

Q

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

A

BioCryst Pharma does not have any upcoming earnings scheduled.

Q

Is BioCryst Pharma (BCRX) going to split?

A

There is no upcoming split for BioCryst Pharma.

Q

What sector and industry does BioCryst Pharma (BCRX) operate in?

A

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.